Similar Articles
1121 Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma
1122 Alcohol and hepatocellular carcinoma: A review and a point of view
1123 Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture
1124 Metformin does not improve survival in patients with hepatocellular carcinoma
1125 Current surgical treatment strategies for hepatocellular carcinoma in North America
1126 Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma
1127 Safety of hepatectomy for elderly patients with hepatocellular carcinoma
1128 Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
1129 Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinoma
1130 Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA